P, M., H, V. B., J, R., M, M., L, D. P., I, D. V., . . . R, M. (2021). Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months. Lung cancer (Amsterdam, Netherlands), 153, 117. https://doi.org/10.1016/j.lungcan.2021.01.012
Chicago Style (17th ed.) CitationP, Masrori, Vaesen Bentein H, Raskin J, Montagna M, De Picker L, De Volder I, Van Schil PE, Janssens A, and Mercelis R. "Caspr2 Autoantibody-associated Morvan Syndrome Predating Thymoma Relapse by 30 Months." Lung Cancer (Amsterdam, Netherlands) 153 (2021): 117. https://doi.org/10.1016/j.lungcan.2021.01.012.
MLA (9th ed.) CitationP, Masrori, et al. "Caspr2 Autoantibody-associated Morvan Syndrome Predating Thymoma Relapse by 30 Months." Lung Cancer (Amsterdam, Netherlands), vol. 153, 2021, p. 117, https://doi.org/10.1016/j.lungcan.2021.01.012.